日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

SLC1A5 is a key regulator of glutamine metabolism and a prognostic marker for aggressive luminal breast cancer.

SLC1A5 是谷氨酰胺代谢的关键调节因子,也是侵袭性管腔型乳腺癌的预后标志物

Alfarsi Lutfi H, Ansari Rokaya El, Erkan Busra, Fakroun Ali, Craze Madeleine L, Aleskandarany Mohammed A, Cheng Kiu Wai, Ellis Ian O, Rakha Emad A, Green Andrew R

Hydroxyacid Oxidase 1, a Glutamine Metabolism-Associated Protein, Predicts Poor Patient Outcome in Luminal Breast Cancer.

羟基酸氧化酶 1 是一种与谷氨酰胺代谢相关的蛋白质,可预测管腔型乳腺癌患者的不良预后

Erkan Busra, MacIntyre Skye, Brown Charlotte, Fakroun Ali, Lashen Ayat G, Mongan Nigel P, Ellis Ian O, Rakha Emad A, Green Andrew R

ATF4 as a Prognostic Marker and Modulator of Glutamine Metabolism in Oestrogen Receptor-Positive Breast Cancer.

ATF4 作为雌激素受体阳性乳腺癌的预后标志物和谷氨酰胺代谢调节因子

Patel Roshni, Alfarsi Lutfi H, El-Ansari Rokaya, Masisi Brendah K, Erkan Busra, Fakroun Ali, Ellis Ian O, Rakha Emad A, Green Andrew R